Bioventus annual operating margin
2019
2020
2021
2022
2023
2024
2025
Bioventus's operating margin was 9.50% for fiscal 2025.
View full Bioventus company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 9.50% | +12.15 pp |
| 2024 | 2024-12-31 | −2.65% | +13.30 pp |
| 2023 | 2023-12-31 | −15.95% | +16.70 pp |
| 2022 | 2022-12-31 | −32.66% | −35.45 pp |
| 2021 | 2021-12-31 | 2.80% | −3.81 pp |
| 2020 | 2020-12-31 | 6.61% | −2.56 pp |
| 2019 | 2019-12-31 | 9.17% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-27 | 12.48% | +0.04 pp |
| Q1 2026 | 2026-03-28 | 6.37% | +2.44 pp |
| Q4 2025 | 2025-12-31 | 12.34% | +7.33 pp |
| Q3 2025 | 2025-09-27 | 8.12% | +5.49 pp |
| Q2 2025 | 2025-06-28 | 12.44% | +33.25 pp |
| Q1 2025 | 2025-03-29 | 3.93% | +0.12 pp |
| Q4 2024 | 2024-12-31 | 5.01% | +4.15 pp |
| Q3 2024 | 2024-09-28 | 2.62% | +0.62 pp |
| Q2 2024 | 2024-06-29 | −20.81% | −25.74 pp |
| Q1 2024 | 2024-03-30 | 3.81% | +81.13 pp |
| Q4 2023 | 2023-12-31 | 0.86% | +13.29 pp |
| Q3 2023 | 2023-09-30 | 2.00% | +100.58 pp |
| Q2 2023 | 2023-07-01 | 4.92% | +7.28 pp |
| Q1 2023 | 2023-04-01 | −77.32% | −59.03 pp |
| Q4 2022 | 2022-12-31 | −12.43% | −10.01 pp |
| Q3 2022 | 2022-10-01 | −98.58% | −97.62 pp |
| Q2 2022 | 2022-07-02 | −2.36% | +2.87 pp |
| Q1 2022 | 2022-04-02 | −18.29% | −45.19 pp |
| Q4 2021 | 2021-12-31 | −2.42% | −8.41 pp |
| Q3 2021 | 2021-10-02 | −0.96% | −9.03 pp |
| Q2 2021 | 2021-07-03 | −5.23% | +2.69 pp |
| Q1 2021 | 2021-04-03 | 26.90% | +10.38 pp |
| Q4 2020 | 2020-12-31 | 5.99% | — |
| Q3 2020 | 2020-09-26 | 8.07% | — |
| Q2 2020 | 2020-06-27 | −7.92% | — |
| Q1 2020 | 2020-03-28 | 16.52% | — |
Over the last five reported fiscal years, Bioventus's operating margin increased from 6.61% to 9.50%, a change of +2.89 percentage points. The latest reported quarter, Q2 2026, shows 12.48%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioventus filings at SEC.gov ↗